Two new cloned human cDNAs encode paralogs of the 85-kDa cytosolic phospholipase A 2 (cPLA 2 ). We propose to call these cPLA 2 ␤ (114 kDa) and cPLA 2 ␥ (61 kDa), giving the name cPLA 2 ␣ to the well known 85-kDa enzyme. cPLA 2 ␤ mRNA is expressed more highly in cerebellum and pancreas and cPLA 2 ␥ more highly in cardiac and skeletal muscle. Sequence-tagged site mapping places cPLA 2 ␤ on chromosome 15 in a region near a phosphoinositol bisphosphate phosphatase. The mRNA for cPLA 2 ␤ is spliced only at a very low level, and Northern blots in 24 tissues show exclusively the unspliced form. cPLA 2 ␤ has much lower activity on 2-arachidonoyl-phosphatidylcholine liposomes than either of the other two enzymes. Its sequence contains a histidine motif characteristic of the catalytic center of caspase proteases of the apoptotic cascade but no region characteristic of the catalytic cysteine. Sequence-tagged site mapping places cPLA 2 ␥ on chromosome 19 near calmodulin. cPLA 2 ␥ lacks the C2 domain, which gives cPLA 2 ␣ its Ca 2؉ sensitivity, and accordingly cPLA 2 ␥ has no dependence upon calcium, although cPLA 2 ␤ does. cPLA 2 ␥ contains a prenyl group-binding site motif and appears to be largely membrane-bound. cPLA 2 ␣ residues activated by phosphorylation do not appear to be well conserved in either new enzyme. In contrast, all three previously known catalytic residues, as well as one additional essential arginine, Arg-566 in cPLA 2 ␣, are conserved in both new enzyme sequences. Mutagenesis shows strong dependence on these residues for catalytic activity of all three enzymes.
Enzymatic breakdown of glycerophospholipids is carried out by numerous pathways, with the production of various bioactive lipids and fatty acids (1) (2) (3) (4) (5) (6) (7) (8) . Diverse phospholipase A 2 (PLA 2 ) 1 enzymes hydrolyze the sn-2 bond of phospholipids, releasing lysophospholipids and fatty acids (9 -11) . Often the released fatty acid is arachidonic acid, whose further metabolism gives rise to several types of bioactive lipids known as eicosanoids, many of which mediate inflammation. Thus PLA 2 enzymes initiate the production of inflammatory mediators (12, 13) , and for that reason they have become targets for the development of anti-inflammatory therapies.
The 85-kDa cytosolic phospholipase A 2 (reviewed in Refs. 12-15) has attracted special interest because it is the only one of numerous PLA 2 s that selectively releases arachidonic acid over other fatty acids (16, 17) . Recent results with transgenic mice ablated for this enzyme (18) have demonstrated its role in allergy and parturition. Several functional regions have been identified within its amino acid sequence, including the C2 or calcium and lipid binding region similar to the C2 regions of other proteins (19) such as the calcium-dependent protein kinase C enzymes; several serine residues capable of activation through phosphorylation (20 -22) ; a hydrophilic region that may have a structural role (13) ; and several residues essential for catalysis, identified by mutagenesis (23) (24) (25) .
The cDNA for the 85-kDa cPLA 2 shows no similarity with the sequences of other known PLA 2 enzymes, and genomic Southern blots reveal no closely related family members (16, 26) . Since the cloning of the 85-kDa cPLA 2 (cPLA 2 ␣ in this report) in 1991 (16, 26) a number of enzymes with PLA 2 activity have been isolated (9) . This report describes two new family members that were molecularly defined through examination of DNA data bases and subsequent full-length cloning. One of these new enzymes lacks the C2 domain, but some of the other above-listed features are found in both new enzymes, called here cPLA 2 ␤ and cPLA 2 ␥. While this paper was under review a report (27) appeared describing cPLA 2 ␥.
EXPERIMENTAL PROCEDURES
Cloning, cDNA Expression, and Assays-cPLA 2 ␤ was originally detected as the human brain EST sequence with GenBank TM accession number R20583, in a BLAST analysis (28) . This EST was obtained from IMAGE and sequenced. By using 5Ј-rapid amplification of cDNA ends (RACE) and 3Ј-RACE with CLONTECH's human brain "Marathon" cDNA, more fragments were obtained which showed additional regions of homology to cPLA 2 ␣ and also showed evident introns, judging by the large number of in-frame terminator codons, much greater length between homologous elements, and loss of alignment with cPLA 2 ␣. Isolation of several additional fragments by traditional cDNA cloning from human brain and pancreas cDNA libraries failed to yield properly spliced sequences. PCR was used to amplify cDNA from the evidently rare mature spliced mRNA that was represented in the same CLON-TECH brain cDNA, using the following primers bearing EcoRI and NotI restriction sites (lowercase) and matching the termini of our cPLA 2 ␤ sequence (uppercase): gagggaattcCTTCATGATGCCAGCTGAGCGCC-GCC for the 5Ј end and ggtggcggccgcCCCGGCCATCAGTGGGGCCTG-CGC for the 3Ј end. The 5Ј-untranslated region of the cPLA 2 ␤ mRNA was difficult to determine, since two separate 5Ј fragment clones that were amplified by 5Ј-RACE appeared, after sequencing, to represent inverted 3Ј termini of unrelated mRNAs accidentally fused to the cPLA 2 ␤ cDNA. cPLA 2 ␥ was discovered in a BLAST analysis as the human brain EST with GenBank TM accession number N56796 encoding a sequence similar to that just C-terminal to the Asp-549 catalytic region of cPLA 2 ␣. Using 5Ј-RACE with the CLONTECH brain cDNA, the additional 5Ј sequence obtained had homology with cPLA 2 ␣ and was identical to another human brain EST with GenBank TM accession number R61677.
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The Further sequencing of R61677 revealed that this IMAGE clone contained the entire coding region for cPLA 2 
␥.
The full-length cDNAs (spliced form for cPLA 2 ␤) were subcloned and introduced into baculovirus DNA by recombination as described (23) . Significant amounts of recombinant proteins were produced (Fig. 3) . Mutant forms of cPLA 2 cDNAs, including those for the His-tagged cPLA 2 s, were each constructed and confirmed by sequence analysis also as described (23) . The His-tagged cPLA 2 forms were modified at the C or N terminus as follows (last or first 3 amino acids of each cPLA 2 are in lowercase): cPLA 2 ␤, . . . rphHHHHH, and cPLA 2 ␥, MHHHHHHAmgs. . . . Western analysis of those proteins was done as described (23) using the penta-His antibody purchased from Qiagen.
For Northern analysis, human multiple tissue RNA blots (CLON-TECH) were probed with 2 ϫ 10 6 cpm/ml 32 P random primer-labeled cPLA 2 ␣, cPLA 2 ␤, cPLA 2 ␥, or ␤-actin cDNA probes, using the procedure recommended by the manufacturer (CLONTECH).
The caspase catalytic histidine consensus motif ( Fig. 1 ) of cPLA 2 ␤ was found by comparison of the sequence to the Prosite data set with the GCG program Findpatterns. The pattern match is nearly perfect, matching 6 of the 7 specified residues exactly, and having alanine (A) where the consensus (27) . Ser-505 is phosphorylated for activation (20 -22) . The C2 domain is boxed, and asterisks indicate the 6 residues contacting Ca 2ϩ through side chain oxygen atoms in the recently solved structure for the cPLA 2 ␣ C2 (37). Five of those are preserved in cPLA 2 ␤ or replaced with another oxygen-bearing side chain, as in the case of Asp-40 of cPLA 2 ␣, replaced by Thr. The caspase catalytic histidine motif (see "Experimental Procedures") is underlined in cPLA 2 ␤ with the catalytic His corresponding to position 560. Small clusters of basic residues (Lys or Arg) are also underlined near the C termini of all three proteins. Shown in bold are the aligned Ser-727 of cPLA 2 ␣, known to be phosphorylated (22) , and Ser-537 of cPLA 2 ␥. There is some additional N-terminal sequence (99 aa) to cPLA 2 ␤, not shown here (see "Experimental Procedures").
square brackets indicate alternative residues for one position. During the writing of this paper, we completed the analysis of one additional EST cDNA clone (GenBank TM accession number R25833) which provided an extension of the 5Ј-untranslated region of cPLA 2 ␤, showing by comparison that the other 5Ј-untranslated region clones we had analyzed contained a 98-bp unspliced intron. The spliced sequence revealed a continuation of the open reading frame for 99 aa before the initiator methionine of Fig. 1 , suggesting that the full length of cPLA 2 ␤ may properly be 1012 aa, particularly in light of the improved Kozak consensus (cagccATGG) at this initiator methionine codon. This information is included in the DNA sequences filed in the listed GenBank TM accession numbers AF065215 and AF065216 for cPLA 2 ␤. The added amino acids increase the predicted protein size to 114,120 daltons, but the protein we expressed here for most experiments (Fig. 3) should be 103 kDa as stated above. The additional 5Ј intron's splice sites also conform quite well to the splice consensus sequences, leaving as unconventional only intron 2 (see "Results and Discussion"), which should subsequently be called intron 3.
The liposome assays for PLA 2 activity were carried out as previously published (23, 30) . The enzymes were assayed in extracts of baculovirus-infected insect cells without centrifugation but otherwise as described (23) . In this assay the activity generally seen for purified cPLA 2 ␣ is 2.2 mol/min/mg protein. To compare this value qualitatively with those of Table I , we estimate that the insect cells produce a minimum of 1% of their total protein as cPLA2 (perhaps a bit less for cPLA 2 ␥), thus predicting a specific activity of at least 20 nmol/min/mg total protein in the lysates for cPLA 2 ␣. Thus the values in Table I show that cPLA 2 ␥ and cPLA 2 ␤ are about 2 and 3 orders of magnitude lower, respectively, than cPLA 2 ␣ in apparent specific activity.
Chromosomal locations were derived from nucleotide sequence matches to STS sequences found on the NCBI Human Gene Map. 2 The genes mentioned for chromosome 15 were listed within the region between markers D15S118 and D15S123 [32-45 cM] or between D15S118 and D15S1016 [32-47 cM] , and those for chromosome 19 were between D19S219 and D19S418 [69 -97 cM]. The calmodulin STS mapping on chromosome 19 bears the designation stSG360 and the Swissprot accession number is P02593.
Sequence Determination and Computer Analysis-The initial EST (expressed sequence tag) sequences were detected using BLAST analysis (28) . The GCG (31) software was used throughout the work, as well as Sequencher for interpretation of DNA sequencing results. All DNA sequencing was done by either of two methods: 1) automated analysis using an Applied Biosystems model 377 DNA sequencer, or 2) standard radioactive analysis using Sequenase reagents from U. S. Biochemical Corp. All sequence data reported were derived from comparison of at least 3 times coverage in coding regions (and often more) and at least 2 times coverage in noncoding regions, all of which included data from both strands. The exon/intron structure shown in Fig. 6 for cPLA 2 ␤ was derived from direct comparison of the sequences of the 8.5-and the 3.0-kb mRNAs.
The 27-bp repeat in cPLA 2 ␥ cDNA was discovered by comparison of three distinct cDNA clones containing from 1 to 3 tandemly repeated copies of the sequence, with one small variation. Each clone contained the sequence CTCCGCACCGGATTCCGGAGCACAAG as shown in Fig.  4 ; however, in the clones bearing two and three copies of this sequence, the first (or first two) copies, reading from 5Ј to 3Ј, differed at one position (underlined): CCTCCGCACCGGATTCCGGAGCCCAAG, bringing them one base closer to the potassium channel sequence (shown as 27 ic* in Fig. 4B ). The iPLA 2 mapping was done using BLAST on GenBank TM accession number MMU88624, the iPLA 2 cDNA, which showed highly significant matches in the 98-kb chromosome 22 genomic fragment AL022322.
RESULTS

Three cPLA2s
Appear Evolutionarily Related-The EST data base of cDNA fragment sequences has grown rapidly to include by now cDNA fragments from a large fraction of human mRNAs. Examination of this data base revealed two ESTs bearing significant hints of similarity to the 85-kDa cPLA 2 , referred to in this paper as cPLA 2 ␣. The EST for cPLA 2 ␤ included the region aligning with the catalytic Ser-228 of cPLA 2 ␣ (23), whereas the EST for cPLA 2 ␥ aligned with Arg-566, which we also knew was required for enzyme activity. 3 Sequencing of these original ESTs and isolation of overlapping cDNA clones (see "Experimental Procedures") revealed cDNAs encoding the two protein sequences compared in Fig. 1 .
This alignment shows that the three cPLA 2 enzyme sequences all have about 30% identity to each other and that the C2 calcium and lipid binding domain of cPLA 2 ␣ has a counterpart in cPLA 2 ␤ but not in the shorter cPLA 2 ␥. Fig. 1 also shows that there is total conservation, among all three sequences, of the three previously published catalytically essential cPLA 2 ␣ amino acids Arg-200, Ser-228, and Asp-549 (23, 24) , as well as Arg-566, which also appears to be essential for catalysis, since all enzyme activity is lost upon changing Arg-566 to alanine. 3 cPLA 2 ␣ contains a mitogen-activating protein kinase motif PXSP, and the Ser-505 in this motif is phosphorylated, activating the enzyme (20 -22) . The PXSP motif is not found in the sequences of either cPLA 2 ␤ or cPLA 2 ␥, and the alignment in that region is weak, suggesting that the phosphorylation activation pathway demonstrated for cPLA 2 ␣ (20 -22) may not be operating for the new enzymes. There are concentrations of basic residues (underlined) at the C termini of all three protein sequences. In addition to the two catalytic regions, a third region of salient conservation, and devoid of gaps, is seen between residues 346 and 396 of cPLA 2 ␣.
Expression, Enzyme Activity, and Chromosomal LocationsNorthern analysis (Fig. 2) shows that messenger RNAs for all three cPLA 2 enzymes are expressed widely, although in most tissues at a low level. The control cPLA 2 ␣ mRNA was expressed more evenly than the others, with heart and pancreas having higher expression ( Fig. 2A) . cPLA 2 ␤ mRNA is expressed strongly in pancreas (Fig. 2B ) and most strongly in cerebellum (Fig. 2D) , whereas cPLA 2 ␥ mRNA is expressed most strongly in skeletal muscle and heart (Fig. 2C) . The ␤-actin control (Fig. 2 , E and F) shows that similar amounts of mRNA were loaded into each lane of the gels. As has been well documented (32) , ␤-actin has higher expressed alternatively spliced forms in heart and skeletal muscle, which are seen in Fig. 2E , lanes 1 and 6.
Both cPLA 2 ␤ and cPLA 2 ␥ proteins were produced in insect cells as done previously for cPLA 2 ␣, and robust expression was obtained for each enzyme (see "Experimental Procedures"), producing clearly enhanced bands among the total set of stained proteins upon SDS electrophoresis (Fig. 3, A and C) . The molecular sizes estimated from these gels, 100 kDa for cPLA 2 ␤ and 60 kDa for cPLA 2 ␥, agree well with the sizes predicted from the cDNA coding regions (102,984 daltons for ␤ and 60,948 for ␥). Because there is a baculovirus protein produced in the infected insect cells that migrate with cPLA 2 ␥ at 60 kDa, we used immunoblotting of cPLA 2 ␤ and cPLA 2 ␥ bearing His-tag additions (see "Experimental Procedures") to confirm that the increased density at 60 kDa was due to cPLA 2 ␥ (Fig. 3B) . The Western analysis of Fig. 3B shows that the appropriate 60-and 100-kDa bands are reactive with the Histag antibody (as well as some apparent hydrolysis products, ensuring that those bands truly represent the cPLA 2 ␤ and -␥ proteins. The "full-length" 1012-aa cPLA 2 ␤ form (see "Experimental Procedures") in lane 4 of Fig. 3A , shows a band near the expected 114 kDa, although it produced only about the same activity as the 103-kDa form (data not shown).
For an initial survey of enzyme activity, insect cell extracts were assayed for enzymatic activity with 1-palmitoyl-2-arachidonoyl-phosphatidylcholine liposomes. Table I shows that while cPLA 2 ␤ and cPLA 2 ␥ are catalytically active their enzymatic activity is several orders of magnitude lower than that of cPLA 2 ␣ (see "Experimental Procedures"), despite the fact that the proteins were present in similar amounts (Fig. 3, A and B,  lanes 1, 2, and 5) . In Fig. 3B we see that the overexposed main bands represent the majority of the cPLA 2 s in their full-length forms, although several apparently degraded forms are also seen. For cPLA 2 ␥ we know that most of the enzyme protein remained bound to membranes due to a lipid anchor (27) , which may have restricted access to the labeled liposomes. For cPLA 2 ␤ the activity, although clearly significantly above the assay background, was also very low (Table I) . 4A shows the cDNA sequence and its translation for cPLA 2 ␥. An interesting feature of this cDNA sequence is a 27-bp imperfect palindrome found before the initiator codon, indicated in Fig. 4A by underlining. This 27-bp segment was found repeated 2 or 3 times in tandem in separate additional cDNA clones encoding cPLA 2 ␥, apparently a result of alternative mRNA splicing.
BLAST analysis against the GenBank TM data base showed that cPLA 2 ␤ and cPLA 2 ␥ both have exact matches in STS sequence entries, corresponding to mapped locations on human chromosomes 15 (STS WI-13757 matches cPLA 2 ␤) and 19 (STS WI-14200 matches cPLA 2 ␥), respectively. Thus since cPLA 2 ␣ has been mapped to human chromosome 1, it is clear that these three related genes cannot lie within a gene cluster, as some related genes do.
Sensitivity to Calcium-In Fig. 1 we can see that cPLA 2 ␣ and cPLA 2 ␤ have a significant alignment in the C2 region. The figure also shows that cPLA 2 ␥ lacks the C2 domain and therefore might be expected to have no Ca 2ϩ requirement for catalytic activity. Accordingly, Fig. 5 shows that this enzyme does not have the calcium requirement displayed by cPLA 2 ␣ (30, 33, 34, and reviewed in Ref. 35 ) activity levels in all samples being somewhat raised, rather than lowered, when calcium is chelated by the presence of 5 mM EDTA. Since our assays were done in crude extracts, the higher activity with EDTA may not necessarily be observed with purified enzyme.
Although the activity of cPLA 2 ␤ was low, it was possible to demonstrate (Table II) its calcium sensitivity, presumably due to its C2-like domain. In 5 mM EDTA the activity, after subtracting the control values, is decreased by 5-or 10-fold relative 2 ␤ and cPLA 2 ␥ The proteins indicated were produced in baculovirus-infected insect cells, and extracts were prepared and assayed (see "Experimental Procedures"). All three cPLA 2 forms typically represent about 1% of total cell protein (see Fig. 3, A and B) . The figure listed for cPLA 2 ␣ is estimated from the well established value for the purified form (17, 18, 24 to that seen in 1 mM Ca 2ϩ . cPLA 2 ␤ Splicing Control-The majority of EST and other cDNA fragments obtained for cPLA 2 ␤ included segments that were obviously introns, both by comparison to rarer spliced fragments and to the sequence of cPLA 2 ␣. In order to obtain a completely spliced cDNA for cPLA 2 ␤, it was necessary to screen using PCR amplification (see "Experimental Procedures"). Consistent with this observation, in Northern blots (Fig. 2, B and  D) the mRNA for cPLA 2 ␤ is seen exclusively in the unspliced form (8.5 kb) rather than in its mature form (3 kb). Fig. 6 compares the major mRNA form and the PCR-amplified spliced form of cPLA 2 ␤ mRNA. The intron/exon structure is shown in Fig. 6A , and the intron boundary sequences are shown in Fig.  6B . Most of the splice junctions conform to the normal consensus for donor and acceptor splice sites (36), but both donor and acceptor sites are poorly conserved for intron 2. Intron 2 consists of 98 nucleotides that are highly homologous to part of an Alu repetitive sequence. No analysis of genomic DNA has been done for cPLA 2 ␤.
Catalytic Activity- Table III shows the loss of cPLA 2 ␤ activ-
FIG. 4.
A, cDNA for cPLA2␥ and its translation. cPLA 2 ␥ is predicted to be a 541-aa protein encoded by a mRNA of at least 2472 nucleotides. The translation is shown above the DNA sequence. Single underlining denotes the 27-bp partial palindrome (see text), the initiator ATG codon, and the AATAAA polyadenylation signal. Double underlining shows the CAAX box at the C terminus of the protein sequence. B, repeated palindrome from the 5Ј-untranslated region of cPLA 2 ␥. 27 bp represents the sequence from cPLA 2 ␥, and 27 ic is its inverted complement, aligned to show its palindromic property. The inverted complement 27 ic* (1-base variant, see "Experimental Procedures") aligns with the forward orientation of the (identical) initiator regions from human and mouse potassium channel protein cDNAs, listed as their GenBank TM accession numbers U04270 and AF012868, respectively. ity seen when the Ser, Arg, or Asp residues aligned with Ser-228, Asp-549, or Arg-566 of cPLA 2 ␣, respectively, are changed to alanine. The loss of activity is not due to failure to produce the mutant proteins, since they are all produced in normal amounts (Fig. 3C) . These are three of the four known catalytically essential residues of cPLA 2 ␣ (23, 24), 3 and this result suggests they serve the same function for cPLA 2 ␤. It is of interest to note a motif (Fig. 1, around His-560, underlined) in cPLA 2 ␤ which includes the catalytic histidine identified in caspase proteases of the apoptosis pathway (29) . 4 It is not clear what the function of this motif might be, especially in light of the fact that there is no semblance of the cysteine-containing motif also essential for the proteolytic activity of caspases. Changing His-560 of cPLA 2 ␤ to alanine left the cPLA 2 activity intact (Table III) , demonstrating that this particular histidine residue is not essential for PLA 2 activity.
A similar analysis of the corresponding conserved residues of cPLA 2 ␥ shows (Table III) that all four aligned conserved residues Arg-54, Ser-82, Asp-285, and Arg-402 are essential for cPLA 2 ␥ activity just as they were shown earlier for cPLA 2 ␣ (24). 3 The mutant proteins were produced in very similar amounts as shown in Fig. 3E . DISCUSSION A considerable variety of phospholipids is present in cells and tissues, considering combinations of head groups, fatty acids, and linkages (ester, ether, and alkyl). It is unlikely that a full detailing of the catalytic repertoires and biological roles of these three enzymes will be accomplished quickly, given such a wide range of possible substrates. We expect that interesting functional differences will be discovered regarding these enzymes as their enzymatic and kinetic properties become fully characterized.
cPLA 2 ␥-In light of extensive studies (19, 35, 37, 38) to characterize the C2 domain of cPLA 2 as giving to the enzyme its sensitivity to Ca 2ϩ , it is satisfying to see in cPLA 2 ␥ an additional confirmation that in this naturally occurring enzyme, whose mRNA is expressed highly in skeletal and heart muscle, the Ca 2ϩ sensitivity is absent without the C2 domain (Fig. 5) .
After much previous work (39) establishing the existence of a calcium-insensitive PLA 2 activity in heart tissue, it is most interesting to find cPLA 2 ␥ mRNA selectively expressed in heart and skeletal muscle (Fig. 2C) . The enzyme iPLA 2 (see Ref. 40 and reviewed in Ref. 41 ), which has no sequence similarity whatever to cPLA 2 ␥, is the only calcium-insensitive cPLA 2 previously known to be expressed in heart. It seems likely that some of the enzyme activity seen in heart tissue may be due to cPLA 2 ␥. Since cPLA 2 ␥ appears to be largely membrane-bound through a lipid anchor motif at its C terminus ( Fig. 4A ; see also Ref. 27) , there may well be separate cell compartments and biological roles for these two cytosolic PLA 2 s in cardiac tissue.
The 27-bp imperfect palindrome shown in Fig. 4A appears in the 5Ј-untranslated region of cPLA 2 ␥ cDNA, and in other clones analyzed this 27-bp segment appeared two or three times as concatenated repeats (not shown), presumably through alternative splicing. A search of GenBank TM , now just over 1 billion nucleotides, revealed that this exact sequence does not appear elsewhere in known genes. Interestingly, the closest match found was 23 of 27 bases, surrounding the initiator methionine codon of a human potassium channel protein, perfectly preserved in its mouse homolog (Fig. 4B) , making a stronger case for a possible functional relationship to translational regulation by these closely related sequence segments.
cPLA 2 ␤-The C2 domain has been shown to mediate calcium sensitivity in cPLA 2 ␣ (20 -22, 38 ). This C2, or calcium and lipid binding, domain is widely distributed among diverse proteins (35) . Five of the six cPLA 2 ␣ side chain oxygen atoms now known to be in contact with calcium (37) are indicated in Fig. 1 by asterisks and are aligned in cPLA 2 ␤, as explained in the figure legend. Consequently, the degree of alignment seen in Fig. 1 may well signify that cPLA 2 ␤ has a functional C2 domain. Despite its low activity in our assay system, the data in Table II support this concept. This activity was also tested (not shown) in the full-length form of cPLA 2 ␤ (i.e. with the extra N-terminal 99 aa), and it showed no higher activity in our assay than the 913-aa form.
It is a mystery why the mRNA for cPLA 2 ␤ is not fully processed in the 24 tissues we examined, and one should be cautious in interpreting this fact. Nevertheless, it should be noted that the spliced cPLA 2 ␤ cDNA (depicted in Fig. 6 ) encoding the cPLA 2 ␤ protein (shown in Fig. 1) was not derived from a prediction but was amplified by reverse transcriptase-PCR from human brain tissue, demonstrating that it is spliced in cells at a low level. The major (unspliced) mRNA form for cPLA 2 ␤ is not necessarily identical to the genomic sequence (i.e. it may represent a stable, partially spliced product); we have not examined chromosomal DNA encoding cPLA 2 ␤.
The intron splice sites (Fig. 6B) were seen to be all similar to the normal GT-AG consensus sequences (36), except for intron 2. Comparison (not shown) of the intron 2 sites to other minor FIG. 5 . Calcium independence of cPLA 2 ␥. Baculovirus-infected insect cell lysates producing cPLA 2 ␥ were prepared as described ("Experimental Procedures") and tested in the liposome assay with or without EDTA to chelate the available free calcium. The indicated amounts of total cell lysate protein were assayed in a total volume of 200 l. The curves are as labeled. The No enzyme curves had 5 mM EDTA (triangles) and 1 mM Ca 2ϩ (circles). Concentrated extracts are inhibitory, allowing greater specific activity to be seen at the lower concentrations.
TABLE II
Calcium dependence of cPLA 2 ␤ Baculovirus-infected insect cell lysates producing cPLA 2 ␥ were prepared and assayed as described (see "Experimental Procedures") using the liposome assay with or without EDTA to chelate the available free calcium. Between 30 and 46 g of cell extract protein was assayed in 200 l. ␤-HT is the His-tag form of cPLA 2 ␤ described under "Experimental Procedures." Values shown, with vector control subtracted (see Table I ), are the average of two measurements, and semicolons separate independently prepared cell lysates. consensus sequences (36) showed that they were not similar to the standard AT-AC consensus or the other known minor forms. Seven cDNA fragments from rat cPLA 2 ␤ cDNA were also sequenced (not shown) and allowed comparison to introns 3-4, and notably the acceptor site of intron 2 (the latter shown in Fig. 6B ), which all had normal GT-AG consensus sequences. Since splicing generally has been observed to follow no requisite order, it does not seem likely that one unusual intron splice site could prevent the normal splicing of other introns. In addition, the introns in the seven rat cPLA 2 ␤ cDNA clones were mostly unspliced, despite the normal consensus sequence at the acceptor site for intron 2. We must conclude that there is no obvious explanation for the inverted ratio of spliced to unspliced cPLA 2 ␤ mRNA. It may be suspected that cPLA 2 ␤ is a pseudogene; however, this does not seem likely, since most pseudogenes have accumulated premature terminator codons randomly within their coding regions, over much shorter spans than the Ͼ100 kDa of cPLA 2 ␤. In addition, conservation of cPLA 2 ␤ is high between human and rat. Seven rat cPLA 2 ␤ cDNA fragments covering 530 aa had 85% identity (not shown) to the human cPLA 2 ␤ sequence, far higher than would be expected for a nonfunctional pseudogene (the introns and 3Ј-untranslated regions were not detectably conserved). It is possible that in some biological setting the mRNA becomes fully spliced, as a form of activation. For example this process may follow the form of splicing regulation seen dramatically for several genes in the inflammatory cytokine pathway, such as tumor necrosis factor-␣, interleukin-2, and interleukin-1␤ (42) (43) (44) . However, in these cases splicing regulation is not nearly as stringently restricted as we see for cPLA 2 ␤. Viruses are known (45) to exert very stringent temporal mRNA splicing control. However, to our knowledge such stringent splicing control has not been previously seen in cellular mRNAs.
Phosphorylation-cPLA 2 ␣ has been shown to have several sites of phosphorylation, which alter the activity of the enzyme (20 -22) . For cPLA 2 ␣, the pattern PXSP seen around Ser-505 has been most studied, but in addition phosphorylation has been detected on serine at positions 437, 454, and especially 727 (22) . Comparison of the sequences for the three enzymes ( Fig. 1 ) reveals that none of these serines is preserved in the alignment, with the lone exception that Ser-727 of cPLA 2 ␣ is aligned with Ser-537 of cPLA 2 ␥, albeit in a region of weak conservation, positioned immediately before the C-terminal CAAX box in cPLA 2 ␥. We conclude that if there are phosphorylation sites in cPLA 2 ␤ or cPLA 2 ␥, they are probably specific to each enzyme and not a conserved feature within the family.
Chromosomal Locations-The three cPLA 2 s are all on different chromosomes, 1, 15, and 19; the calcium-independent iPLA 2 can be mapped to human chromosome 22 (see "Experimental Procedures"); and the 14-kDa secreted cPLA 2 s are spread further still (10) . However, as functionally related genes are sometimes clustered together in the genome, it is notable that within the same region of human chromosome 15 as cPLA 2 ␤ (see "Experimental Procedures"), there are 14 mapped known genes, including the one encoding 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase ␤2. This phosphodies- FIG. 6 . A, introns and exons of the major and minor forms of cPLA 2 ␤ mRNA. Distances, marked below in kb, were derived by comparing the assembly of major cDNA fragments sequenced to the minor PCR fragment that encodes cPLA 2 ␤. The letters i1 to i4 are placed over the introns. The uppercase letters indicate the exons that encode the C2 domain and the amino acids that align ( Fig. 1) with the catalytically essential Arg-200 and Ser-228 (R and S) and Asp-549 and Arg-566 (D and R) of cPLA 2 ␣. B, intron borders for human cPLA2␤, showing alignment with consensus donor and acceptor sequences for the predominant human U2 (GT-AG) splice sites (36) , shown in uppercase letters in the first line. Intron borders are in lowercase, and exon borders are in uppercase letters. Conventional ambiguity codes used here for nucleotides are K ϭ G or T; R ϭ A or G; Y ϭ C or T. Hyphens indicate splice sites. The human cPLA2␤ borders are labeled i1, i2, i3, and i4. Asterisks below the border sequences indicate agreement with the consensus. A rat sequence (labeled rat i2) for the acceptor site of intron 2 is also shown.
TABLE III Test for essential catalytic center elements
The cPLA 2 ␤ and -␥ mutant proteins indicated were produced in baculovirus-infected insect cells, and extracts were prepared and assayed (see "Experimental Procedures"). The cPLA 2 ␥ mutants were all made in the His-tag (HT) form. Values shown, with vector control subtracted (see Table I ), are the average of duplicates of two independently infected samples of Sf9 insect cells. terase ␤2 has the ability to produce and to degrade PIP 2 , the compound shown (46, 47) to activate cPLA 2 ␣ by about 40-fold. This nearby chromosomal location to cPLA 2 ␤ suggests a relationship, for example possibly PIP 2 can activate cPLA 2 ␤. It will be interesting to explore this possibility. The vicinity of cPLA 2 ␥ on chromosome 19 (see "Experimental Procedures") contains 20 known mapped genes, notable among them being apolipoprotein E and calmodulin. While certainly apolipoprotein E is prominent in many areas, particularly cardiovascular biology (48, 49) , the precise connection with cPLA 2 ␥ may not be immediately evident. However, the relationship postulated between calmodulin and another calciumindependent cytosolic PLA 2 (50) makes this chromosomal location intriguing. Those authors postulated that iPLA 2 may achieve calcium responsiveness and membrane access through association with calmodulin. Although cPLA 2 ␥ likely achieves its membrane access through a lipid anchor suggested by the prenyl group-binding site motif (27) , also called a "CAAX box," at its C terminus, the close chromosomal location for cPLA 2 ␥ and calmodulin also suggests the possibility of a functional relationship between these two proteins.
Catalysis and Conservation-As noted above, all four catalytically essential amino acids are strictly conserved in cPLA 2 ␤ and cPLA 2 ␥. The subtilase aspartate motif surrounding Asp-549 of cPLA 2 ␣ is conserved quite well in cPLA 2 ␥ and in cPLA 2 ␤ at least as well as in the yeast orthologs (compare Fig. 1 here and Fig. 1 of Ref. 24) . Mutation studies support the idea that these four residues are essential for catalysis in all three of these paralogs (Ref. 24 and Table III) .
Comparison of these cPLA 2 family members makes it evident that there is an additional significant conserved region in all three cPLA 2 s, lying between amino acids 350 and 400 in cPLA 2 ␣ (see Fig. 1 ), a region also noticeably conserved among cPLA 2 ␣ orthologs of six species (Fig. 6 of Ref. 24) . Although several other regions of the sequence have been defined as to their function, this one has not. Mosior et al. (47) recently made a striking observation investigating the discovery of Leslie and Channon (46) that PIP 2 can activate cPLA 2 ␣ to a remarkable extent, providing a direct link between the phospholipase C and cPLA 2 signaling pathways. It is tempting to suspect that this conserved region might mediate the PIP 2 response, and it will be interesting to see whether the two new enzymes also have this property.
Conclusions-As analysis of the human genome accelerates, protein families are rapidly expanding, and searches for possible new members are becoming more fruitful. However, whereas estimates are that well over 70% of human genes are now represented in the EST DNA data bases, it is likely that genes with very low levels of expression or highly selective tissue distributions will elude discovery until even after genomic DNA sequencing is complete. There may be additional paralogs of cPLA 2 , since the present ones were only found because their traces of homology could be recognized in the EST data base as being significant. Exploration of gene families has yielded much information about structure-function relationships and understanding of molecular mechanisms and biological roles. Comparison of these three cPLA 2 paralogs is likely to advance our understanding of lipid mediator and signaling pathways, which reach into many important biological and disease categories.
